---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-158523"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2022-05-24T23:59:59+00:00"
generated_at: "2026-06-25T07:44:10.680062+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Eliem Therapeutics shareholders elect three directors, ratify PwC as auditor at 2022 annual meeting

## Summary
- Robert Azelby, Judith Dunn, Adam Rosenberg elected Class I directors with >20M votes for each.
- PricewaterhouseCoopers LLP ratified as independent auditor for FY2022 with 24,137,141 votes for, 4,086 against.
- Broker non-votes: 1,346,296 on director elections; none on auditor ratification.

## SEC filing metadata
- accession: 0001193125-22-158523
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2022-05-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312522158523/0001193125-22-158523-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312522158523/d535085d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-158523
- JSON: https://secwatch.observer/filing/0001193125-22-158523.json
- Plain text: https://secwatch.observer/filing/0001193125-22-158523.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.